4D Molecular (NASDAQ: FDMT) CLO exercises options, sells 9,810 shares at $12
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
4D Molecular Therapeutics Chief Legal Officer Scott Bizily reported an exercise-and-sell stock transaction. On June 23, 2026, he exercised options to acquire 9,810 shares of common stock at $4.14 per share, then sold 9,810 shares in an open-market trade at $12.00 per share.
After these transactions, he holds 18,427 common shares directly and 63,785 stock options with a $4.14 exercise price expiring in 2035. A footnote also notes 5,023 shares previously purchased under the company’s Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 9,810 shares ($117,720)
Net Sell
3 txns
Insider
Bizily Scott
Role
Chief Legal Officer
Sold
9,810 shs ($118K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 9,810 | $0.00 | -- |
| Exercise | Common Stock | 9,810 | $4.14 | $41K |
| Sale | Common Stock | 9,810 | $12.00 | $118K |
Holdings After Transaction:
Stock Option (Right to Buy) — 63,785 shares (Direct, null);
Common Stock — 18,427 shares (Direct, null)
Footnotes (1)
- Reflects 5,023 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Key Figures
Shares sold: 9,810 shares
Sale price: $12.00 per share
Options exercised: 9,810 shares
+4 more
7 metrics
Shares sold
9,810 shares
Open-market sale of common stock on June 23, 2026 at $12.00
Sale price
$12.00 per share
Price for 9,810 common shares sold on June 23, 2026
Options exercised
9,810 shares
Common stock acquired via option exercise at $4.14 per share
Exercise price
$4.14 per share
Stock option exercise price for 9,810 underlying shares
Shares held after
18,427 shares
Direct common stock ownership after transactions
Options remaining
63,785 options
Stock options outstanding after exercise, expiring March 5, 2035
ESPP shares
5,023 shares
Common stock purchased under Employee Stock Purchase Plan, Rule 16b-3 exempt
Key Terms
Employee Stock Purchase Plan, Rule 16b-3, Stock Option (Right to Buy), Vesting Commencement Date, +1 more
5 terms
Employee Stock Purchase Plan financial
"Reflects 5,023 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3 regulatory
"purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
Vesting Commencement Date financial
"on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What insider transaction did FDMT’s Chief Legal Officer report on June 23, 2026?
The Chief Legal Officer exercised stock options for 9,810 FDMT shares at $4.14 and sold 9,810 shares at $12.00 in an open-market transaction, combining a derivative exercise with a same‑day share sale.